Merck suffers less than rivals on health reform
FiercePharma - 18 minutes ago
There's one Big Pharma that's not losing much to healthcare reform, relatively speaking. Merck (NYSE: MRK) says higher Medicaid rebates will cost it $170 million this year, and next year's tab ...
http://digg.com/u1UU77
No comments:
Post a Comment